ROYCE & ASSOCIATES LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,718,550
-68.5%
45,000
-53.1%
0.02%
-70.2%
Q4 2022$5,462,400
+43.9%
96,0000.0%0.06%
+32.6%
Q3 2022$3,796,000
-10.1%
96,0000.0%0.04%0.0%
Q2 2022$4,224,000
+231.0%
96,000
+200.0%
0.04%
+290.9%
Q1 2022$1,276,000
+10533.3%
32,000
+2566.7%
0.01%
Q2 2014$12,000
-98.6%
1,200
-98.2%
0.00%
-100.0%
Q1 2014$839,000
-50.3%
66,075
-41.4%
0.00%
-60.0%
Q4 2013$1,689,000
+3.6%
112,697
-23.7%
0.01%0.0%
Q3 2013$1,631,000
+145.6%
147,697
+76.6%
0.01%
+150.0%
Q2 2013$664,00083,6220.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders